Literature DB >> 24804366

Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.

Mayer B Davidson, Petra Duran, Martin L Lee.   

Abstract

OBJECTIVE: To evaluate community screening using HbA1c levels in high risk African Americans and Latinos in those not known to have diabetes.
DESIGN: HbA1c levels were measured in 1542 African Americans and Latinos aged > or = 40 years with one or more of the following risk factors: family history in first degree relatives, waist circumference > or = 40 inches in males or > or = 35 inches in females, and hypertension, either treatment for or a measured BP of > or = 140/ 90 mm Hg. Oral glucose tolerance tests (OGTT) were offered to those meeting the HbA1c criterion for pre-diabetes.
SETTING: Churches, community health fares, senior citizen sites. PARTICIPANTS: People without known diabetes. MAIN OUTCOME MEASURES: Proportion of people meeting the HbA1c criteria for prediabetes (5.8-6.4%) and diabetes (> or = 6.5%).
RESULTS: 32% had one, 50% had two and 18% had three risk factors. By HbA1c criteria, 40% had pre-diabetes and 25% had diabetes. Increased waist circumference was the most common risk factor followed by a positive family history, and lastly, hypertension. Each individual risk factor was significantly (P < .001) and progressively more common as glycemia increased. Each additional risk factor increased the odds of pre-diabetes or diabetes by 2- to 4-fold. In individuals with pre-diabetes who underwent an OGTT, 59% were normal, 35% had pre-diabetes and only 6% had diabetes.
CONCLUSIONS: Community screening of high risk African Americans and Latinos with HbA1c levels identifies a large proportion of people with pre-diabetes and diabetes. Those identified with pre-diabetes are unlikely to meet the OGTT criteria for diabetes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24804366      PMCID: PMC4287403     

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  34 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Utility of A1C for diabetes screening in the 1999 2004 NHANES population.

Authors:  Catherine Buell; Duclie Kermah; Mayer B Davidson
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

3.  Polytomous logistic regression analysis could be applied more often in diagnostic research.

Authors:  C J Biesheuvel; Y Vergouwe; E W Steyerberg; D E Grobbee; K G M Moons
Journal:  J Clin Epidemiol       Date:  2007-06-29       Impact factor: 6.437

4.  Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Authors:  Catherine L Martin; James Albers; William H Herman; Patricia Cleary; Barbara Waberski; Douglas A Greene; Martin J Stevens; Eva L Feldman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

5.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

6.  Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey.

Authors:  Jinan B Saaddine; Anne Fagot-Campagna; Deborah Rolka; K M Venkat Narayan; Linda Geiss; Mark Eberhardt; Katherine M Flegal
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

Review 7.  Diabetes health disparities: a systematic review of health care interventions.

Authors:  Monica E Peek; Algernon Cargill; Elbert S Huang
Journal:  Med Care Res Rev       Date:  2007-10       Impact factor: 3.929

8.  Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.

Authors:  William H Herman; Yong Ma; Gabriel Uwaifo; Steven Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

9.  Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?

Authors:  James W Albers; William H Herman; Rodica Pop-Busui; Catherine L Martin; Patricia Cleary; Barbara Waberski
Journal:  Diabetes Care       Date:  2007-07-20       Impact factor: 19.112

Review 10.  Diabetic complications. The importance of glucose control.

Authors:  J S Skyler
Journal:  Endocrinol Metab Clin North Am       Date:  1996-06       Impact factor: 4.741

View more
  7 in total

1.  Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program.

Authors:  Andrew D Kerkhoff; Susana Rojas; Douglas Black; Salustiano Ribeiro; Susy Rojas; Rebecca Valencia; Jonathan Lemus; Joselin Payan; John Schrom; Diane Jones; Simone Manganelli; Shalom Bandi; Gabriel Chamie; Valerie Tulier-Laiwa; Maya Petersen; Diane Havlir; Carina Marquez
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Black Men's Perceptions and Knowledge of Diabetes: A Church-Affiliated Barbershop Focus Group Study.

Authors:  Joyce Balls-Berry; Christopher Watson; Sandeep Kadimpati; Andre Crockett; Essa A Mohamed; Italo Brown; Miguel Valdez Soto; Becky Sanford; Michele Halyard; Jagdish Khubchandani; Lea Dacy; Olga Idriss Davis
Journal:  J Racial Ethn Health Disparities       Date:  2015-03-13

3.  Employer-Based Screening for Diabetes and Prediabetes in an Integrated Health Care Delivery System: A Natural Experiment for Translation in Diabetes (NEXT-D) Study.

Authors:  Sara R Adams; Deanne M Wiley; Andromache Fargeix; Victoria George; Romain S Neugebauer; Julie A Schmittdiel
Journal:  J Occup Environ Med       Date:  2015-11       Impact factor: 2.162

4.  The Association between HbA1c and Cardiovascular Disease Markers in a Remote Indigenous Australian Community with and without Diagnosed Diabetes.

Authors:  Luke W Arnold; Wendy E Hoy; Suresh K Sharma; Zhiqiang Wang
Journal:  J Diabetes Res       Date:  2016-02-17       Impact factor: 4.011

5.  From Iceberg of Pre-diabetes to Poor Glycemic Control in Diabetics: An Elderly Based Study in Shiraz, South of Iran.

Authors:  Behnam Honarvar; Morteza Banakar; Nazi Hassani; Yasaman Movahednezhad; Zahra Gheibi; Kamran Bagheri Lankarani
Journal:  Int J Prev Med       Date:  2019-10-09

6.  Early detection of type 2 diabetes in socioeconomically disadvantaged areas in Stockholm - comparing reach of community and facility-based screening.

Authors:  Linda Timm; Katri Harcke; Ida Karlsson; Kristi Sidney Annerstedt; Helle Mölsted Alvesson; Nouha Saleh Stattin; Birger C Forsberg; Claes-Göran Östenson; Meena Daivadanam
Journal:  Glob Health Action       Date:  2020-12-31       Impact factor: 2.640

7.  Effectiveness of an Integrated Engagement Support System to Facilitate Patient Use of Digital Diabetes Prevention Programs: Protocol for a Randomized Controlled Trial.

Authors:  Katharine Lawrence; Danissa V Rodriguez; Dawn M Feldthouse; Donna Shelley; Jonathan L Yu; Hayley M Belli; Javier Gonzalez; Sumaiya Tasneem; Jerlisa Fontaine; Lisa L Groom; Son Luu; Yinxiang Wu; Kathleen M McTigue; Bonny Rockette-Wagner; Devin M Mann
Journal:  JMIR Res Protoc       Date:  2021-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.